StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.22−0.28 (-6.22%)

Close on Nov 20, 2026Market cap $52.99MP/E –Yield –

Neuraxis revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Neuraxis's revenue for the twelve months ending Jun 30, 2026 was $5.32M, up 65.2% year over year. For fiscal 2025 it was $3.57M, up 32.9% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.57M+32.9%
FY2024Dec 31, 2024$2.69M+9.2%
FY2023Dec 31, 2023$2.46M-8.4%
FY2022Dec 31, 2022$2.68M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.93M+115.7%
Q1 FY2026Mar 31, 2026$1.61M+79.5%
Q4 FY2025Dec 31, 2025$968.13K+27.2%
Q3 FY2025Sep 30, 2025$811.41K+21.7%
Q2 FY2025Jun 30, 2025$894.09K+46.2%
Q1 FY2025Mar 31, 2025$895.66K+38.5%
Q4 FY2024Dec 31, 2024$761.17K+43.2%
Q3 FY2024Sep 30, 2024$666.63K+39.6%
Q2 FY2024Jun 30, 2024$611.50K-5.3%
Q1 FY2024Mar 31, 2024$646.64K-19.7%
Q4 FY2023Dec 31, 2023$531.46K-13.3%
Q3 FY2023Sep 30, 2023$477.46K-22.8%
Q2 FY2023Jun 30, 2023$646.02K-5.4%
Q1 FY2023Mar 31, 2023$805.11K–
Q4 FY2022Dec 31, 2022$613.08K–
Q3 FY2022Sep 30, 2022$618.81K–
Q2 FY2022Jun 30, 2022$682.58K–

More Neuraxis figures

See a number that looks wrong?